AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24872684 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at 30 Hz and 3.2 g for 3 months
Number of subjects: 38
Study 24872684 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 38
Study 22836351 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga-based rehabilitation intervention (twice per week for 8 weeks)
Number of subjects: 47
Study 22836351 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 47
Study 20150405 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialect Variation (DVAR)
Number of subjects: 617
Study 17688462 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dopaminergic drive in mania
Number of subjects: 0
Study 17688462 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dopamine precursors in Parkinson's disease
Number of subjects: 0
Study 17688462 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclical process of dopaminergic transmission
Number of subjects: 0
Study 16132530 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient visits every third month
Number of subjects: 472
Study 16132530 — intervention group
Group type: COMPARATOR
Intervention: Outpatient visits every sixth month
Number of subjects: 472
Study 16132530 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine examinations
Number of subjects: 472
Study 16132530 — intervention group
Group type: COMPARATOR
Intervention: Examinations on clinical grounds
Number of subjects: 472
Study 12402427 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraportal chemotherapy with 10 mg/body of mitomycin and 500 mg/m2 of 5-FU for 7 days followed by oral 5-FU
Number of subjects: 125
Study 12402427 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of 5-FU
Number of subjects: 125
Study 12402427 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraportal chemotherapy for stage III colorectal cancer
Number of subjects: 125
Study 9922016 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 356
Study 9922016 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal mupirocin
Number of subjects: 356
Study 9922016 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketoconazole
Number of subjects: 356
Study 9922016 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluconazole
Number of subjects: 356
Study 9922016 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 356
Study 9922016 — intervention group
Group type: COMPARATOR
Intervention: Non-ciprofloxacin group
Number of subjects: 356
Study 9922016 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin group
Number of subjects: 356
Study 9922016 — intervention group
Group type: EXPERIMENTAL
Intervention: Antifungal prophylaxis
Number of subjects: 356
Study 7472899 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric rehydration
Number of subjects: 24
Study 7472899 — intervention group
Group type: COMPARATOR
Intervention: Intravenous rehydration
Number of subjects: 24
Study 2107237 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose rt-PA (2 mg/kg body weight over 3 h)
Number of subjects: 175
Study 2107237 — intervention group
Group type: COMPARATOR
Intervention: Standard dose rt-PA (1.25 mg/kg over 3 h)
Number of subjects: 175
Study 2107237 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose rt-PA (2 mg/kg)
Number of subjects: 175
Study 2107237 — intervention group
Group type: COMPARATOR
Intervention: Standard dose rt-PA (1.25 mg/kg)
Number of subjects: 175
Study 31767184 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrification after 15-20 μm zona pellucida thinning and blastocoel collapse before vitrification (Group 2)
Number of subjects: 0
Study 31767184 — intervention group
Group type: EXPERIMENTAL
Intervention: Zona pellucida thinning immediately after thawing (Group 3)
Number of subjects: 0
Study 31767184 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser assisted hatching (LAH) of fresh blastocysts (Group 4)
Number of subjects: 0
Study 31767184 — intervention group
Group type: COMPARATOR
Intervention: Fresh blastocysts without treatment (Group 5)
Number of subjects: 0
Study 31767184 — intervention group
Group type: COMPARATOR
Intervention: Vitrification and thawing without any treatment (Group 1)
Number of subjects: 0
Study 30738649 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN) 5 mg once daily for 4 days
Number of subjects: 1149
Study 30738649 — intervention group
Group type: COMPARATOR
Intervention: Sham dressing
Number of subjects: 1149
Study 30738649 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN)
Number of subjects: 1149
Study 29137465 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium-Zinc-Calcium-Vitamin D co-supplementation (100 mg magnesium, 4 mg zinc, 400 mg calcium, 200 IU vitamin D, twice a day for 12 weeks)
Number of subjects: 60
Study 29137465 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice a day for 12 weeks)
Number of subjects: 60
Study 25958221 — intervention group
Group type: EXPERIMENTAL
Intervention: Site visit intervention at Site A
Number of subjects: 0
Study 25958221 — intervention group
Group type: COMPARATOR
Intervention: Control sites (Site B and Site C)
Number of subjects: 0
Study 25958221 — intervention group
Group type: COMPARATOR
Intervention: Site A (intervention) vs Site B and Site C (controls)
Number of subjects: 0
Study 23709328 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eyedrops
Number of subjects: 20
Study 21723695 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib for 6 weeks postoperatively
Number of subjects: 107
Study 21723695 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks postoperatively
Number of subjects: 107
Study 20920179 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment
Number of subjects: 648
Study 20920179 — intervention group
Group type: EXPERIMENTAL
Intervention: Worsening of akathisia (measured by the Barnes Akathisia Scale) during the first two weeks of treatment
Number of subjects: 648
Study 20920179 — intervention group
Group type: EXPERIMENTAL
Intervention: Worsening of symptoms of depression/anxiety (subscale score on the Positive and Negative Syndrome Scale) during the first two weeks of treatment
Number of subjects: 648
Study 20920179 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of antipsychotic use in the prior year
Number of subjects: 648
Study 20920179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-existing depression
Number of subjects: 648
Study 20920179 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 648
Study 20920179 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of substance use disorder
Number of subjects: 648
Study 17256807 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 154
Study 17256807 — intervention group
Group type: COMPARATOR
Intervention: Antireflux surgery
Number of subjects: 154
Study 17256807 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (after dose adjustment)
Number of subjects: 154
Study 15177796 — intervention group
Group type: EXPERIMENTAL
Intervention: Wathand Box
Number of subjects: 0
Study 15177796 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateralized place phase of the grooved pegboard task
Number of subjects: 0
Study 15177796 — intervention group
Group type: COMPARATOR
Intervention: Waterloo Handedness Questionnaire
Number of subjects: 0
Study 15177796 — intervention group
Group type: EXPERIMENTAL
Intervention: Two pegboard tasks
Number of subjects: 0
Study 15177796 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger tapping
Number of subjects: 0
Study 15177796 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip strength
Number of subjects: 0
Study 12596444 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiMAL test for Plasmodium falciparum (parallel design)
Number of subjects: 189
Study 12596444 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiMAL test for Plasmodium vivax (parallel design)
Number of subjects: 189
Study 12596444 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiMAL test for Plasmodium falciparum (sequential design)
Number of subjects: 189
Study 12596444 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiMAL test for Plasmodium vivax (sequential design)
Number of subjects: 189
Study 12596444 — intervention group
Group type: COMPARATOR
Intervention: Thick smear test (control)
Number of subjects: 189
Study 9649929 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 15
Study 9649929 — intervention group
Group type: COMPARATOR
Intervention: Control (no warfarin)
Number of subjects: 15
Study 8587457 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 20
Study 8587457 — intervention group
Group type: COMPARATOR
Intervention: Pentaerithrityltetranitrate (PETN) treatment
Number of subjects: 20
Study 8587457 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (no treatment)
Number of subjects: 20
Study 2761917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular interferon alpha‐2b (3 x 10(6) U (3 MU)/m2 daily for 3 weeks, total dose 63 MU/m2)
Number of subjects: 203
Study 2761917 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon alpha‐2b (thrice‐weekly injections of 3 MU/m2 for 4 weeks, total dose 36 MU/m2)
Number of subjects: 203
Study 2761917 — intervention group
Group type: EXPERIMENTAL
Intervention: Diathermocoagulation
Number of subjects: 203
Study 2761917 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 203
Study 2761917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular interferon alpha‐2b
Number of subjects: 203
Study 2761917 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon alpha‐2b
Number of subjects: 203
Study 709269 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration cytology
Number of subjects: 255
Study 709269 — intervention group
Group type: EXPERIMENTAL
Intervention: All three screening tests (clinical examination, xeromammography, fine-needle aspiration cytology)
Number of subjects: 255
Study 709269 — intervention group
Group type: COMPARATOR
Intervention: Xeromammography
Number of subjects: 255
Study 31264943 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (2.5‐10.0 mg per day)
Number of subjects: 42
Study 31264943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 28183846 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-CAP
Number of subjects: 0
Study 28183846 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 0
Study 25243769 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stick exercises (SSEs) for six months followed by routine care for six months
Number of subjects: 105
Study 25243769 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stick exercises (SSEs)
Number of subjects: 105
Study 25243769 — intervention group
Group type: COMPARATOR
Intervention: Ordinary care for 12 months
Number of subjects: 105
Study 22635060 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 81
Study 22635060 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 81
Study 22635060 — intervention group
Group type: EXPERIMENTAL
Intervention: Later Usual Care + CBT (UC + CBT)
Number of subjects: 81
Study 21585643 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid negative pressure vacuum extraction
Number of subjects: 662
Study 21585643 — intervention group
Group type: COMPARATOR
Intervention: Stepwise negative pressure vacuum extraction
Number of subjects: 662
Study 19687345 — intervention group
Group type: EXPERIMENTAL
Intervention: ET‐1 infusion (5 pmol/min) after diesel exhaust exposure
Number of subjects: 13
Study 19687345 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ‐123 infusion (10 nmol/min) after diesel exhaust exposure
Number of subjects: 13
Study 19687345 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined BQ‐123 and BQ‐788 administration after diesel exhaust exposure
Number of subjects: 13
Study 19687345 — intervention group
Group type: COMPARATOR
Intervention: Filtered air exposure
Number of subjects: 13
Study 16032375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice (750 ml/day for 2 weeks)
Number of subjects: 20
Study 16032375 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 20
Study 16032375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 20
Study 12634538 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 10
Study 12634538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 10853843 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy followed by irradiation (CTRT)
Number of subjects: 155
Study 10853843 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (RT)
Number of subjects: 155
Study 9085062 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentoplasty after abdominoperineal resection (n = 64)
Number of subjects: 165
Study 9085062 — intervention group
Group type: COMPARATOR
Intervention: No omentoplasty after abdominoperineal resection (n = 101)
Number of subjects: 165
Study 8222816 — intervention group
Group type: EXPERIMENTAL
Intervention: Antireflux therapy
Number of subjects: 12
Study 8222816 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal esophageal infusion of 0.1 N HCl
Number of subjects: 12
Study 8222816 — intervention group
Group type: COMPARATOR
Intervention: Distal esophageal infusion of 0.9 percent saline solution
Number of subjects: 12
Study 8222816 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline cough count
Number of subjects: 12
Study 8222816 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal pH monitoring (EPM)
Number of subjects: 12
Study 8222816 — intervention group
Group type: EXPERIMENTAL
Intervention: Cough induced by acid
Number of subjects: 12
Study 2419687 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine 200 mg IMI
Number of subjects: 9
Study 2419687 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine 300 mg IMI
Number of subjects: 9
Study 2419687 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine 400 mg IMI
Number of subjects: 9
Study 2419687 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine 500 mg IMI
Number of subjects: 9
Study 2419687 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine 400 mg IMI followed by 360 mg orally at 2 and 12 h
Number of subjects: 9
Study 2419687 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine 400 mg IMI in 12 healthy volunteers
Number of subjects: 9
Study 31926869 — intervention group
Group type: EXPERIMENTAL
Intervention: Playground (physically-active lessons)
Number of subjects: 172
Study 31926869 — intervention group
Group type: COMPARATOR
Intervention: Classroom (seated lessons)
Number of subjects: 172
Study 30109847 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 293
Study 30109847 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 293
Study 27322164 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) TB drugs
Number of subjects: 1000
Study 27322164 — intervention group
Group type: COMPARATOR
Intervention: Loose formulation (LF) TB treatment regimens
Number of subjects: 1000
Study 27322164 — intervention group
Group type: EXPERIMENTAL
Intervention: Both FDC and LF
Number of subjects: 1000
Study 24002013 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% sodium tetradecyl sulphate
Number of subjects: 40
Study 24002013 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% polidocanol
Number of subjects: 40
Study 24002013 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 40
Study 23227581 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 60
Study 23227581 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 60
Study 23227581 — intervention group
Group type: COMPARATOR
Intervention: Historical Control Group (HCG)
Number of subjects: 60
Study 20171939 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 15 mm Hg
Number of subjects: 10
Study 20171939 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 20 mm Hg
Number of subjects: 10
Study 20171939 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 25 mm Hg
Number of subjects: 10
Study 20171939 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 15, 20, or 25 mm Hg
Number of subjects: 10
Study 18598093 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg alone
Number of subjects: 16
Study 18598093 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 25 mg with DRV/r 400/100 mg
Number of subjects: 16
Study 18598093 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with DRV/r and sildenafil
Number of subjects: 16
Study 15992513 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol ester 1.6 g/day
Number of subjects: 0
Study 15992513 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol ester 1.6 g/day
Number of subjects: 0
Study 15992513 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol ester 2.6 g/day
Number of subjects: 0
Study 15992513 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 12074224 — intervention group
Group type: COMPARATOR
Intervention: Rotary preparation with diamond burs
Number of subjects: 48
Study 12074224 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonicflex 2000 L/N (HS)
Number of subjects: 48
Study 12074224 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental air scaler (HS.EXP)
Number of subjects: 48
Study 12074224 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezon Cavity System (PCS)
Number of subjects: 48
Study 12074224 — intervention group
Group type: EXPERIMENTAL
Intervention: All systems combined
Number of subjects: 48
Study 12074224 — intervention group
Group type: EXPERIMENTAL
Intervention: HS.EXP
Number of subjects: 48
Study 12074224 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 48
Study 9583287 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (isolated systolic hypertension)
Number of subjects: 15
Study 9583287 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (systolic and diastolic hypertension)
Number of subjects: 15
Study 7645448 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger endoscope (Q10)
Number of subjects: 52
Study 7645448 — intervention group
Group type: COMPARATOR
Intervention: Smaller endoscope (PQ20)
Number of subjects: 52
Study 7645448 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Q10 and PQ20)
Number of subjects: 52
Study 2706044 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate freshwater fish diet (3.7 fish meals per week, about 1 g of n‐3 fatty acids daily)
Number of subjects: 100
Study 2706044 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of freshwater fish diet (in dose response study)
Number of subjects: 100
Study 2706044 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of freshwater fish diet (1.5 and 2.3 fish meals per week)
Number of subjects: 100
Study 796938 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg daily)
Number of subjects: 24
Study 796938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 796938 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (4 g daily)
Number of subjects: 24
Study 29846605 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 day sequential therapy
Number of subjects: 620
Study 29846605 — intervention group
Group type: COMPARATOR
Intervention: 10 day bismuth quadruple therapy containing high-dose esomeprazole
Number of subjects: 620
Study 29846605 — intervention group
Group type: COMPARATOR
Intervention: 10 day bismuth quadruple therapy
Number of subjects: 620
Study 27124695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control (IG, target 140 mg/dL)
Number of subjects: 164
Study 27124695 — intervention group
Group type: COMPARATOR
Intervention: Moderate glycemic control (MG, target 180 mg/dL)
Number of subjects: 164
Study 27124695 — intervention group
Group type: COMPARATOR
Intervention: Case-matched analysis (24 cases with hypoglycemia vs. 24 controls without)
Number of subjects: 164
Study 25412669 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative electroacupuncture at PC6, ST36, and ST37 bilaterally with electrical stimulation twice a day for 20 min
Number of subjects: 0
Study 25412669 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupuncture at pseudo-acupoints of PC6, ST36, and ST37
Number of subjects: 0
Study 25412669 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (routine treatment without electroacupuncture)
Number of subjects: 0
Study 23138518 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (200 mg hydroxychloroquine sulfate)
Number of subjects: 54
Study 23138518 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (200 mg hydroxychloroquine sulfate)
Number of subjects: 54
Study 23138518 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 54
Study 20152680 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 21
Study 20152680 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush
Number of subjects: 21
Study 20152680 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic toothbrush
Number of subjects: 21
Study 20152680 — intervention group
Group type: COMPARATOR
Intervention: Electric toothbrush, Manual toothbrush, Ultrasonic toothbrush
Number of subjects: 21
Study 18073358 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric care management (2 years of home-based care management by a nurse practitioner and social worker)
Number of subjects: 951
Study 18073358 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric care management
Number of subjects: 951
Study 18073358 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 951
Study 16398596 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 0
Study 16398596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0